SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-23-000374
Filing Date
2023-03-28
Accepted
2023-03-28 17:27:17
Documents
57
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K jatt-20221231x10k.htm   iXBRL 10-K 1376193
2 EX-31.1 jatt-20221231xex31d1.htm EX-31.1 13794
3 EX-31.2 jatt-20221231xex31d2.htm EX-31.2 14485
4 EX-32.1 jatt-20221231xex32d1.htm EX-32.1 7371
5 EX-32.2 jatt-20221231xex32d2.htm EX-32.2 7079
  Complete submission text file 0001410578-23-000374.txt   6262050

Data Files

Seq Description Document Type Size
6 EX-101.SCH jatt-20221231.xsd EX-101.SCH 66133
7 EX-101.CAL jatt-20221231_cal.xml EX-101.CAL 26898
8 EX-101.DEF jatt-20221231_def.xml EX-101.DEF 293787
9 EX-101.LAB jatt-20221231_lab.xml EX-101.LAB 470934
10 EX-101.PRE jatt-20221231_pre.xml EX-101.PRE 400077
51 EXTRACTED XBRL INSTANCE DOCUMENT jatt-20221231x10k_htm.xml XML 818004
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40598 | Film No.: 23770772
SIC: 2836 Biological Products, (No Diagnostic Substances)